Real-time enrollment status for this fibrolamellar hepatocellular carcinoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:45 PM UTC
| NCT Number | NCT06027086 |
| Recruiting Status | Recruiting |
| Condition | Fibrolamellar Hepatocellular Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | February 12, 2026 (Feb 12, 2026) |
As of July 18, 2026: Clinical trial NCT06027086 is currently recruiting participants. This phase1 study for fibrolamellar hepatocellular carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06027086 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06027086 was last updated Feb 12, 2026 (February 12, 2026). HelloStudys verifies this status automatically.